ANGELA WILKINS: Open Payments
NPI 1619932613 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,342 in 128 payments from 21 companies in 2025. Trend: 2023 $2,218 · 2024 $3,020 · 2025 $2,342
Food & beverage: $2,342
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $371 |
| Novo Nordisk Inc | 16 | $369 |
| ABBVIE INC. | 26 | $341 |
| PFIZER INC. | 19 | $265 |
| GlaxoSmithKline, LLC. | 10 | $190 |
| Merck Sharp & Dohme LLC | 7 | $148 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $95 |
| Amgen Inc. | 6 | $91 |
| Lilly USA, LLC | 4 | $78 |
Products named: AIRSUPRA, QULIPTA, TRELEGY ELLIPTA, Rybelsus, Ozempic, CAPVAXIVE, PREVNAR 20, LEQVIO.
Industry payments across KY — which companies pay providers there.
